Company: ACBM
Filing Date: 2025-07-11
Form Type: 10-Q
Source: 0001640334-25-001169
Chunk: 20

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-11
Form: 10-Q
Item: Item 1
Chunk 20
---
 in operating activities:        Imputed interest - related parties  2,367   919 Amortization of deferred stock compensation   8,060,983   11,784,300 Provision for doubtful accounts  480,000   - Provision for purchase deposit write-off  12,000   - Changes in operating assets and liabilities:        Accounts receivable  158,500   319,500 Inventories  -   (296,000)Prepaid expenses  (3,815)  (3,573)Accounts payable and accrued expenses  76,465   (5,297)Net cash used in operating activities  (2,833)  (136,913)         CASH FLOWS FROM FINANCING ACTIVITIES        Advances from related parties  252   57,853 Net cash provided by financing activities  252   57,853          Net change in cash  (2,581)  (79,060)Cash at beginning of period  5,852   95,248 Cash at end of period $3,271  $16,188          SUPPLEMENTAL CASH FLOW INFORMATION:        Cash paid for income taxes $-  $- Cash paid for interest $-  $- 

The accompanying notes are an integral part of these unaudited financial statements.

 7Table of Contents

ACRO BIOMEDICAL CO., LTD.

Notes to Financial Statements

(Unaudited)

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS Acro Biomedical Co., Ltd. (the “Company”) is a Nevada corporation incorporated on September 24, 2014 under the name Killer Waves Hawaii, Inc. On January 30, 2017, the Company’s corporate name was changed to Acro Biomedical Co., Ltd. The Company’s business is the sale of cordyceps related products. Cordyceps is a fungus that is used in traditional Chinese medicine. During the second and third quarters of 2021, the Company engaged consultants to take the initial steps to develop and implement a research and development and marketing program. These consultants are working independently and report to the chief executive officer. As of the date of this report, the research and development efforts have not developed any products, the contracts